CRISPR/Cas9

被引：4

作者：

Mizuno, Naoaki ^{[1
]}

Mizutani, Eiji ^{[1
]}

Sato, Hideyuki ^{[1
]}

Kasai, Mariko ^{[1
]}

Nakauchi, Hiromitsu ^{[1
,2
]}

Yamaguchi, Tomoyuki ^{[1
]}

机构：

[1] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Minato Ku, Tokyo, Japan

[2] Stanford Univ, Sch Med, Dept Genet, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA

来源：

BIO-PROTOCOL | 2019年 / 9卷 / 13期

关键词：

CRISPR/Cas9; Adeno-associated viral vector; Trans-zona pellucida; Intra-embryo genome editing; Ribonucleoprotein electroporation; Large fragment knock-in; ELECTROPORATION;

D O I：

10.21769/BioProtoc.3295

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Intra-embryo genome editing by CRISPR/Cas9 has enabled rapid generation of gene knockout animals. However, large fragment knock-in directly into embryos' genome is still difficult, especially without microinjection of donor DNA. Viral vectors are good transporters of knock-in donor DNA for cell lines, but seemed unsuitable for pre-implantation embryos with zona pellucida, glycoprotein membrane surrounding early embryos. We found adeno-associated virus (AAV) can infect zygotes of various mammals through intact zona pellucida. AAV-mediated donor DNA delivery following Cas9 ribonucleoprotein electroporation enables large fragment knock-in without micromanipulation.

引用

页数：10

共 50 条

[21] CRISPR/Cas9 therapeutics: progress and prospects
Li, Tianxiang
Yang, Yanyan
Qi, Hongzhao
Cui, Weigang
Zhang, Lin
Fu, Xiuxiu
He, Xiangqin
Liu, Meixin
Li, Pei-feng
Yu, Tao
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
[22] Applications of the CRISPR/Cas9 system in murine cancer modeling
Zuckermann, Marc
Kawauchi, Daisuke
Gronych, Jan
BRIEFINGS IN FUNCTIONAL GENOMICS, 2017, 16 (01) : 25 - 33
[23] CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
Tang, Lichun
Zeng, Yanting
Du, Hongzi
Gong, Mengmeng
Peng, Jin
Zhang, Buxi
Lei, Ming
Zhao, Fang
Wang, Weihua
Li, Xiaowei
Liu, Jianqiao
MOLECULAR GENETICS AND GENOMICS, 2017, 292 (03) : 525 - 533
[24] Examination of CRISPR/Cas9 design tools and the effect of target site accessibility on Cas9 activity
Lee, Ciaran M.
Davis, Timothy H.
Bao, Gang
EXPERIMENTAL PHYSIOLOGY, 2018, 103 (04) : 456 - 460
[25] Recent Advances in CRISPR/Cas9 Delivery Strategies
Yip, Bon Ham
BIOMOLECULES, 2020, 10 (06)
[26] CRISPR/CAS9, the king of genome editing tools
A. V. Bannikov
A. V. Lavrov
Molecular Biology, 2017, 51 : 514 - 525
[27] Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
Duan, Li
Ouyang, Kan
Xu, Xiao
Xu, Limei
Wen, Caining
Zhou, Xiaoying
Qin, Zhuan
Xu, Zhiyi
Sun, Wei
Liang, Yujie
FRONTIERS IN GENETICS, 2021, 12
[28] The landscape of CRISPR/Cas9 for inborn errors of metabolism
Leal, Andres Felipe
Fnu, Nidhi
Benincore-Florez, Eliana
Herreno-Pachon, Angelica Maria
Echeverri-Pena, Olga Yaneth
Almeciga-Diaz, Carlos Javier
Tomatsu, Shunji
MOLECULAR GENETICS AND METABOLISM, 2023, 138 (01)
[29] The evolution of CRISPR/Cas9 and their cousins: hope or hype?
Chaudhary, Kulbhushan
Chattopadhyay, Anirudha
Pratap, Dharmendra
BIOTECHNOLOGY LETTERS, 2018, 40 (03) : 465 - 477
[30] The expanding footprint of CRISPR/Cas9 in the plant sciences
Schaeffer, Scott M.
Nakata, Paul A.
PLANT CELL REPORTS, 2016, 35 (07) : 1451 - 1468

← 1 2 3 4 5 →